Harnessing the Power of AI for Rapid Drug Discovery
At the core of Cistron Therapeutics is our proprietary AI platform, designed to transform the drug discovery process. Traditional methods of drug discovery can be time-consuming and costly, but with AI, we can speed up this process exponentially. By analyzing vast libraries of peptides and small molecules, our platform quickly identify potential drug candidates with a high likelihood of success.
Peptide Screening
Peptides—short chains of amino acids—play an essential role in targeting specific cancer cells. By using AI to analyze peptide libraries, we can identify those that are most likely to interact with cancer cells in a way that halts their growth or destroys them entirely.
Small Molecule Screening
Small molecules are critical in blocking cancer’s pathways. With our AI-powered tools, we can pinpoint molecules that have the highest potential to disrupt cancer growth. This allows us to discover new treatments faster, with more precision than traditional methods.
Integrated Screening Process
At Cistron, our AI doesn’t work in silos. It integrates data from both peptide and small molecule screening, ensuring that every potential therapy is evaluated from multiple angles. This multi-layered approach allows us to refine treatments and ensure that they are as effective as possible before reaching clinical trials.
